Original ArticlesBaseline Characteristics and Mortality Outcomes of Control Group Participants and Eligible Non-Responders in the NELSON Lung Cancer Screening Study
Under an Elsevier user license
open archive
Key Words
Selection bias
Refusal to participate
Mass screening and Lung cancer
Cited by (0)
The NELSON trial is financially supported by “ZonMW: the Netherlands Organisation for Health Research and Development” (grant number 120610015), “KWF: Dutch Cancer Society” (grant number EMCR 2007–3857), “Erasmus MC trust fund”, “Health Insurance Innovation Foundation”, “G. Ph. Verhagen Stichting”, “Rotterdam Oncologic Thoracic Steering committee” (ROTS), Roche for providing a grant for the performance of proteomics-research, Siemens Germany for providing four digital workstations, “Stichting tegen Kanker” and “Vlaamse Liga tegen kanker”. The funding sources had only financial roles.
The NELSON trial is registered under registration number ISRCTN63545820 at www.trialregister.nl.
Disclosure: The authors declare no conflict of interest.
Copyright © 2015 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.